We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.
DBCLS will be closed for summer break from August 12 (Wed), 2026 - August 17 (Mon), 2026. After August 18 (Tue), we will respond to requests or questions which are received during this period. We sincerely apologize for any inconvenience this may cause and thank you for your kind understanding and cooperation.
Aims: Gene expression analysis of diseases caused by abnormal RNA splicing
Methods: RNA-Seq for a cellular RNA
Targets: Familial Dysautonomia
Dataset ID | Access type | Type of data | Release date | |
|---|---|---|---|---|
| JGAD000248 | Controlled-access (Type I) | NGS (RNA-seq) | 2021-03-12 | |
Name | URL |
|---|---|
| No data | |
Name | Title | Project number |
|---|---|---|
| Program for Promoting Platform of Genomics based Drug Discovery, Japan Agency for Medical Research and Development (AMED) | Development of genetic disease medicine by pharmacogenomics analysis ofspliceswitching compounds |
|
Title | DOI | Datasets |
|---|---|---|
| Therapeutic manipulation of IKBKAP mis-splicing with a small molecule to cure familial dysautonomia. | https://doi.org/10.1038/s41467-021-24705-5 | |
Principal Investigator | Affiliation | Country/Region | Research title | Period of data use | Data in use (Dataset ID) |
|---|---|---|---|---|---|
| Hamada Michiaki | Waseda University | Japan | Construction of RNA-targeted Drug Discovery Database | 2023-01-05—2027-10-31 | |